Aug 18, 2022 04:05PM
Jul 28, 2022 09:05AM
Jul 28, 2022 09:05AM
Jun 9, 2022 09:05AM
May 18, 2022 09:06AM
May 18, 2022 09:05AM
May 16, 2022 04:05PM Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results
May 10, 2022 09:06AM
May 10, 2022 09:05AM
May 9, 2022 09:05AM
Apr 28, 2022 09:05AM
Apr 28, 2022 09:05AM
Apr 19, 2022 09:05AM
Mar 16, 2022 09:06AM Clarus Therapeutics (CRXT) Announces Phase 4 Clinical Trial of JATENZO for the Treatment of Hypogonadal Men with Chronic Kidney Disease
Mar 16, 2022 09:05AM
Feb 24, 2022 08:00AM
Nov 30, 2021 09:05AM
Nov 30, 2021 09:05AM
Nov 18, 2021 04:05PM
Oct 26, 2021 09:06AM
Oct 26, 2021 09:05AM Clarus Therapeutics Announces Two Notices of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)
Oct 14, 2021 09:05AM
Sep 16, 2021 09:05AM

324,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All